Table 1

Baseline characteristics of the study population

CharacteristicAll populationCLIFT–CLIFT+
Non-SLESLE
New diagnosisPreviously diagnosed
n (%)22281 (36.5)11 (5)47 (21.2)83 (37.4)
Mean age (SD), years49.3 (19)53.9 (21.2)56.1 (21.8)47.6 (17)44.8 (16.5)
Sex, n (%)
Women188 (84.7)6974171
Men34 (15.3)124612
Ana titter; median (IQR)1/320 (1/160- 1/640)1/160 (1/80- 1/640)1/320 (1/160- 1/640)1/160 (1/60-1/320)1/640 (1/320- 1/1280)
AC-1 pattern; n (%)129 (64.2)38 (55.9)6 (54.5)21 (51.2)64 (79)
dsDNA FEIA, median UI/ml (IQR)24 (15.7-50.5)18 (13-33)21 (15-29)26 (15-49)34 (19-81)
dsDNA FEIA, n (%)
10-15 IU/ml5529 (35.8)3 (27.3)12 (25.5)11 (13.3)
16-49 IU/ml11040 (49.4)6 (54.6)25 (53.2)39 (46.1)
 ≥50 IU/ml5712 (14.8)2 (18.2)10 (21.3)33 (39.8)
  • AC-1, ICAP nomenclature for the homogeneous ANA pattern; CLIFT, Crithidia luciliae indirect immunofluorescence test; dsDNA, double-stranded DNA; FEIA, fluorescence enzyme immunoassay.